OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/15/2025
Back to search
Official data from USPTO
DEGLUSTEROL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DEGLUSTEROL
ST13
US500000079377826Class
1, 5
Filing
79377826
Registration
7349782
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/15/2025
Trademark type
Word
Nice classes
1, 5
Filing date
07/13/2023
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
02/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
HUDSON, TAMARA
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CAREGEN CO., LTD.
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biomedical compoundspeptides for industrial purposes; oligopeptides for industrial purposes; biomedical compoundspeptide substrates for scientific purposes; biomedical compoundspeptides for laboratory or research useother than for medical purposes; peptides being raw materials for industrial use for dietetic purposesother than for medical purposes; proteins for use in the manufacture of food supplements; proteins for the food industry; enzymes for industrial purposes; proteins for industrial use; proteins being raw material for industrial use; proteins for use in the manufacture of food and beverages; proteins for use in manufacture; proteins for use in the manufacture of cosmetics; chemicals used in industry and science; biochemical preparations for scientific purposes; biomedical compoundssynthetic peptides for use in the manufacture of food supplements for blood sugar management; cultures of microorganismsother than for medical and veterinary use; chemical additives for use in the manufacture of food; enzymes for the food industry; amino acids for industrial purposesfor laboratory or research use
Class 5
Nutraceutical preparations for blood sugar control; nutraceuticals for use as a dietary supplement; biochemical preparations for medical or veterinary purposes for the treatment of diabetes; biotechnological preparations for medical purposes for the treatment of diabetes; powdered nutritional supplement drink mixes; pharmacological preparations for skin care; pharmaceuticals for the treatment of diabetes; medical preparations for slimming purposes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; anti-diabetic pharmaceuticals; pharmaceutical preparations for health care for the treatment of diabetes; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycemia; hypoglycemic agents; synthetic peptides for pharmaceutical purposes for the treatment of diabetes; medicines for human purposes for the treatment of diabetes; seaweed-based dietary supplements for diabetics; vegetables-based dietary supplements for diabetics; dietary supplements for diabetics based on Chinese matrimony vine; dietary supplements for diabetics based on the root of arrowroots; dietary supplements for diabetics based on Solomon's seal; meat-based dietary supplements for diabetics; whey-based dietary supplements for diabetics; dietary supplements for diabetics based on processed oils and fats for food; dietary supplements for diabetics based on preserved fish; dietary supplements for diabetics based on processed algae
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/26/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/25/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/03/2025
FIMP
FINAL DISPOSITION PROCESSED
01/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/14/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/08/2023
RFNT
REFUSAL PROCESSED BY IB
11/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/13/2023
RFRR
REFUSAL PROCESSED BY MPU
10/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/28/2023
CNRT
NON-FINAL ACTION WRITTEN
09/27/2023
DOCK
ASSIGNED TO EXAMINER
09/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/31/2023
Continuous trademark protection
Get notified about every new filing that threatens DEGLUSTEROL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.